夜久圭介

ヤクケイスケ | Yaku Keisuke

所属機関・部署：
職名：講師

研究分野 (3件)：薬理学 , 代謝、内分泌学 , 栄養学、健康科学

研究キーワード (2件)：メタボロミクス , NAD代謝

競争的資金等の研究課題 (4件)：

論文 (33件)：

Mathieu Membrez, Eugenia Migliavacca, Stefan Christen, Keisuke Yaku, Jennifer Trieu, Alaina K. Lee, Francesco Morandini, Maria Pilar Giner, Jade Stiner, Mikhail V. Makarov, et al. Trigonelline is an NAD+ precursor that improves muscle function during ageing and is reduced in human sarcopenia. Nature Metabolism. 2024
Miyuki Nomura, Mai Ohuchi, Yoshimi Sakamoto, Kei Kudo, Keisuke Yaku, Tomoyoshi Soga, Yuki Sugiura, Mami Morita, Kayoko Hayashi, Shuko Miyahara, et al. Niacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinoma. Nature Communications. 2023. 14. 1
Shintaro Yamaguchi, Daiki Kojima, Tooba Iqbal, Shotaro Kosugi, Michael P Franczyk, Nathan Qi, Yo Sasaki, Keisuke Yaku, Kenji Kaneko, Kenichiro Kinouchi, et al. Adipocyte NMNAT1 expression is essential for nuclear NAD+ biosynthesis but dispensable for regulating thermogenesis and whole-body energy metabolism. Biochemical and biophysical research communications. 2023. 674. 162-169
Keisuke Yaku, Takashi Nakagawa. NAD+ Precursors in Human Health and Disease: Current Status and Future Prospects. Antioxidants & redox signaling. 2023
Yoshiko Nakagawa-Nagahama, Masaki Igarashi, Masaomi Miura, Kosuke Kashiwabara, Keisuke Yaku, Yuichiro Fukamizu, Toshiya Sato, Takanobu Sakurai, Takashi Nakagawa, Takashi Kadowaki, et al. Blood levels of nicotinic acid negatively correlate with hearing ability in healthy older men. BMC Geriatrics. 2023. 23. 1

学歴 (3件)：

経歴 (4件)：

受賞 (5件)：

2022/11 - 日本薬理学会第96回日本薬理学会年会優秀ポスター賞 Inhibition of CD38 promotes muscle regeneration
2021/12 - 富山大学医学部長賞
2013/09 - 大阪市立大学学長奨励賞
2011/10 - 日本栄養食糧学会近畿支部若手研究者奨励賞
2011/10 - Society for Free Radical Research International Young Investigators Award

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

夜久 圭介